Science news articles about 'market exclusivity'

... of inexpensive bioequivalent generic versions of these drugs after the brand-name manufacturer's market exclusivity period ends. Some patients and physicians have expressed concern that generic ...

The days of market exclusivity could soon come to an end for the biotech industry if Congress moves forward with plans to allow generic biologics on the U.S. market.

... length of time brand-name drugs are on the market before generic drugs can enter, because ... research projects in return for extended data or market exclusivity. A 2007 report from The National Academies ...